Pre-Op Opioid Use Tied to Higher Post-Op Dependence

Share this content:
Pre-Op Opioid Use Tied to Higher Post-Op Dependence
Pre-Op Opioid Use Tied to Higher Post-Op Dependence

(HealthDay News) -- Greater preoperative opioid use predicts increased immediate postoperative opioid demand and decreased incidence of postoperative opioid independence among spine surgery patients, according to a study published in the Dec. 1 issue of Spine.

Sheyan J. Armaghani, M.D., from the Vanderbilt University School of Medicine in Nashville, Tenn., and colleagues assessed self-reported daily opioid consumption preoperatively (converted into morphine equivalent amounts) and at the 12-month postoperative point in 583 patients undergoing spine surgery.

The researchers found that the median preoperative morphine equivalent amount for the group was 8.75 mg. More than half of patients (55 percent) reported some degree of opioid use. Increased intraoperative opioid demand was significantly associated with younger age, more invasive surgery, anxiety, and primary surgery (P < 0.05). Similarly, younger age, anxiety, and greater preoperative opioid use were significantly associated with increased immediate postoperative opioid demand (P < 0.05). There was a significant decreased incidence of opioid independence 12 months postoperatively with more invasive surgery, anxiety, revision surgery, and greater preoperative opioid use (P < 0.01).

"Patients may benefit from preoperative counseling that emphasizes minimizing opioid use prior to undergoing spine surgery," the authors write.

Relevant financial activities outside the submitted work were disclosed: consultancy, grants.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »